GlycoMimetics Inc (GLYC)
0.2375
-0.03
(-9.70%)
USD |
NASDAQ |
Jun 17, 16:00
0.24
0.00 (0.00%)
After-Hours: 07:46
GlycoMimetics Market Cap: 15.31M for June 17, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| June 17, 2024 | 15.31M |
| June 14, 2024 | 16.95M |
| June 13, 2024 | 17.44M |
| June 12, 2024 | 16.95M |
| June 11, 2024 | 17.19M |
| June 10, 2024 | 16.69M |
| June 07, 2024 | 16.59M |
| June 06, 2024 | 16.78M |
| June 05, 2024 | 17.47M |
| June 04, 2024 | 18.95M |
| June 03, 2024 | 17.64M |
| May 31, 2024 | 17.47M |
| May 30, 2024 | 17.66M |
| May 29, 2024 | 16.54M |
| May 28, 2024 | 17.21M |
| May 24, 2024 | 17.41M |
| May 23, 2024 | 17.61M |
| May 22, 2024 | 18.20M |
| May 21, 2024 | 17.75M |
| May 20, 2024 | 18.62M |
| May 17, 2024 | 19.30M |
| May 16, 2024 | 18.12M |
| May 15, 2024 | 17.41M |
| May 14, 2024 | 17.79M |
| May 13, 2024 | 16.92M |
| Date | Value |
|---|---|
| May 10, 2024 | 17.19M |
| May 09, 2024 | 19.21M |
| May 08, 2024 | 19.24M |
| May 07, 2024 | 19.69M |
| May 06, 2024 | 20.33M |
| May 03, 2024 | 117.94M |
| May 02, 2024 | 110.85M |
| May 01, 2024 | 104.41M |
| April 30, 2024 | 116.01M |
| April 29, 2024 | 99.90M |
| April 26, 2024 | 105.70M |
| April 25, 2024 | 110.21M |
| April 24, 2024 | 119.56M |
| April 23, 2024 | 118.27M |
| April 22, 2024 | 116.01M |
| April 19, 2024 | 124.07M |
| April 18, 2024 | 139.21M |
| April 17, 2024 | 146.95M |
| April 16, 2024 | 138.57M |
| April 15, 2024 | 145.34M |
| April 12, 2024 | 154.68M |
| April 11, 2024 | 161.45M |
| April 10, 2024 | 157.90M |
| April 09, 2024 | 172.73M |
| April 08, 2024 | 166.93M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
15.31M
Minimum
Jun 17 2024
555.03M
Maximum
Jul 15 2019
131.97M
Average
118.02M
Median
Sep 13 2021
Market Cap Benchmarks
| Altimmune Inc | 419.74M |
| Lyell Immunopharma Inc | 553.22M |
| Amicus Therapeutics Inc | 2.974B |
| InfuSystems Holdings Inc | 135.44M |
| Nanoviricides Inc | 22.45M |
Market Cap Related Metrics
| Price to Book Value | 0.5296 |
| Price | 0.2375 |
| Earnings Yield | -244.2% |